Frencken Group -Integrated technology solutions

Looking for a trusted Stock Remisier?
Augustine works closely with a small group of clients - providing regular market updates, Bazi & astrology wealth insights, and clear guidance to invest with confidence.

📩 Check out my profile here today!

Excerpts from UOB KayHian report

Frencken Group (SGX: E28)

  • Frencken Group weak 1Q22 earnings of S$12.8m (-12.6% yoy, +1.7% qoq) was impacted by rising cost pressures and disruptions in the automobile industry.
  • We believe the global automobile industry will continue to be plagued by an extended period of slow production due to the semiconductor chip shortage and prolonged Russia-Ukraine conflict, which would negatively impact Frencken’s automobile segment.
We have lowered our target price to S$1.63 (from S$2.06). Maintain BUY.

Growth across most but the automobile segment

Frencken Group’s (Frencken) 1Q22 revenue of S$198.4m (+9.3% yoy) was led by growth from the semiconductor (+15.5% yoy), analytical & life sciences (+16.7% yoy) and industrial automation segments, while sales in the medical segment remained relatively stable. However, the automobile segment (-10.7% yoy) was impacted by constrained customer demand as a result of:
  • semiconductor chip supply chain challenges, and
  • disruptions arising from the Russia-Ukraine conflict, which hosts assembly plants for automobile components ranging from electrical cables to catalytic converters and seatbelts.

Frencken Group cost pressures mount

Gross margin narrowed in 1Q22 to 15.4% (1Q21: 17.3%, 4Q21: 15.3%), due to higher prices of raw materials, freight and energy. While Frencken’s manufacturing facilities were not impacted by the COVID-19-related lockdowns across China, those of its customers were, and finished products were unable to be shipped across. Over the longer term, however, we believe Frencken is able to pass on a portion of the higher costs incurred to the customers.

Frencken Group 2H22 to be sequentially better

Management is working to mitigate cost inflation pressures through operational initiatives and is anticipating signs of easing in 2H22. On the outlook for 1H22 relative to 2H21 (hoh basis), we expect growth in the semiconductor, analytical & life sciences and automobile segments, stable performance in the industrial automation segment, and lower revenue in the medical segment

Continued growth in the semiconductor segment to buffer automobile slowdown

We expect the semiconductor sub-segment to contribute 39% of 2022 revenue, an increase from 38% in 2021 (2020: 30%). The relatively more profitable semiconductor segment is anticipated to help bolster a sufficient buffer for the group amid the volatile period that the automobile industry is undergoing.

Continuing investments for longer-term growth

For 2022, a similar amount of investment has been set aside for growth capex and acquisitions (2021: S$33.9m). Frencken has earmarked capex to add manufacturing capacity to facilitate upgrades and expansion programmes across its plants in Europe, Malaysia and Singapore. This would imply higher overheads for Frencken in the near term from increased depreciation expenses, as well as added overheads from acquisitions.

Valuation/Recommendation

Maintain BUY with lower target price of S$1.63 (previously S$2.06). From a previous valuation peg of 13.1x (+1SD to historical mean), we have adjusted our valuation peg to 10.4x 2022F PE, or Frencken’s historical mean PE range We believe the global automobile industry will face an extended period of slow production amid adjustments in the global supply chain. We maintain the view that the current forward PE valuation of 6.9x for Frencken is attractive due to its diverse stream of revenue sources, which would help the company stand out amid a volatile macro environment.
Frencken 1 year price chart
You can find the full report here and the company website here

About the author Augustine

Be A Valued Client of Augustine in Lim&Tan Securities
Receive Augustine’s regular stock updates via Telegram plus full access to his private client hub with exclusive research, astrology and Bazi insights.
(Exclusive Readings for Clients Only)

Check Out Our Latest Articles

4 Singapore Small Cap Stocks That Could Ride the Next Market Rally

When market sentiment turns upbeat and investors begin looking beyond the large-cap names for fresh drivers of growth, Singapore’s small cap stocks could quietly offer outsized upside. With interest rates stabilising, infrastructure spending picking up, and niche sectors recovering, several overlooked companies may shine in the next market rally. Here are four SGX-listed small-caps worth

Read More

🔍 Which Investing Style Matches Your Personality?

You don’t need to be the next Warren Buffett to succeed in investing. But you do need to find your own investing style – so that you compound your wealth that fits your personality, lifestyle, and long-term goals. The truth is, there’s no “one size fits all” approach. Some investors love diving into spreadsheets. Others

Read More

These 7 Common Investing Mistakes are Holding You Back

Investing in the stock markets can be tricky and you will probably lose hell a lot of money even before making any if you lack the right guidance. Thus, as a beginner, it’s important to avoid making the common mistakes that others have made. In fact, these mistakes offer paramount lessons for you to cut

Read More